Psoriasis is a chronic autoimmune inflammatory disease that remains active for a long
period, even for life in most patients. The impact of psoriasis on health is not only limited to …

Secukinumab is an anti-interleukin (IL)-17A IgG1-κ monoclonal antibody approved for
psoriasis, psoriatic arthritis, and ankylosing spondylitis. Its efficacy is well documented, but …

Objectives To estimate the association of Janus kinase inhibitors (JAKi) with the incidence of
malignancy, compared with placebo, tumour necrosis factor (TNF)-α inhibitors (TNFi) and …

Epithelial cells that participated in wound repair elicit a more efficient response to future
injuries, which is believed to be locally restricted. Here we show that cell adaptation …

Background Methotrexate (MTX) use has been suspected of increasing the risk of skin
cancer. The aim of this investigation was to examine the association between the use of …

Psoriasis is associated with several comorbidities ranging from cardiovascular comorbidity
and mental disorders to other immune mediated inflammatory diseases. However, most of …

Introduction:'Chronic inflammatory immune-related skin disease'(ISDs) is an umbrella term
grouping together heterogeneous entities characterized by chronic inflammation potentially …

Background Molecular mechanisms underlying inflammation-associated breast tumor
growth are poorly studied. S100A7, a pro-inflammatory molecule has been shown to …

Psoriasis and psoriatic arthritis (PsA) have been recently considered as chronic systemic
inflammatory disorders. Over the past decades, enormous evidence indicates that patients …

Purpose Although patients aged> 70 years are subject to early oral cavity squamous cell
carcinoma (E-OCSCC), evidence is currently lacking regarding the probable outcomes of …